Why did Madrigal Pharmaceuticals (MDGL) rise today?
Madrigal Pharmaceuticals (MDGL) stock surged on Monday after the company announced positive results from a phase 3 clinical study evaluating its experimental drug resmetirom as a treatment for nonalcoholic steatohepatitis…